Doug Hampton Company and Yale University Hospital seeking participants with GA for Phase 1 trials of medicine FDA-approved for other ailments NEW HAVEN, Conn., June 2, 2023 /PRNewswire/ — TWi Biotechnology (TWiB), a clinical stage biopharmaceutical company specializing in development of repositioned drugs for unmet medical needs, is currently seeking participants for a Phase 1 clinical trial … Read more
Mitra® und hemaPEN ® erhalten die behördliche Zulassung als Medizinprodukte für die Remote-Blutprobenentnahme im Gesundheitswesen, für klinische Studien und für Überwachungsprogramme zu Hause in Europa und im Vereinigten Königreich. MELBOURNE, Australien, 2. Juni 2023 /PRNewswire/ — Trajan Scientific and Medical, ein führender Anbieter von analytischen und Life Sciences-Produkten und -Lösungen, gab heute die behördliche Zulassung seiner … Read more
STOCKHOLM, June 2, 2023 /PRNewswire/ — Sobi® will present data at the EHA (European Haematology Association) hybrid congress taking place in Frankfurt, Germany 8-11 June, 2023, highlighting the company’s commitment in rare haematological diseases. During the congress, Sobi will present important new data on haemophilia, immune thrombocytopenia, relapsed or refractory diffuse large b-cell lymphoma (DLBCL), and paroxysmal … Read more
STOCKHOLM, June 2, 2023 /PRNewswire/ — Medivir AB (NASDAQ Stockholm: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, announces today that a safe dose has been established for treatment with the drug candidate fostroxacitabine bralpamide (fostrox) in combination with Keytruda® in the initial dose escalation … Read more
NEW YORK, June 2, 2023 /PRNewswire/ — The global yoga mat market size is estimated to grow by USD 2,937.23 million from 2022 to 2027, according to Technavio. The market is estimated to grow at a CAGR of 5.84%. North America accounted for the highest market share of the global market in 2022 and is estimated to … Read more
Research Report Focuses on Top Companies and Crucial Drivers, Current Growth Dynamics, Futuristic Opportunities, and New Product/Project Launches NEW YORK, June 2, 2023 /PRNewswire/ — The wheelchair market to grow by USD 1,527.89 million at CAGR of 7.56% from 2022 to 2027, according to the latest research report from Technavio. The growth of the market depends on several … Read more
the essential This rare and little-known disease seriously complicates the daily life of Sylvie Theil, a young 36-year-old from Bigourdane. In addition to repeated trips to the toilet, up to 15 times a night, she has to deal with recurring pain. Sporty, she organizes a collective challenge on June 11 at Lac de Bours. Last … Read more
the essential An experienced school teacher, Anne has been teaching since the start of the 2022 school year at Lavelanet in the priority education network. She recounts her obstacle course to gain access to a school doctor and considers her students abandoned by the public authorities. At the end of the line, Anne* is exhausted. … Read more
HONG KONG, June 1, 2023 /PRNewswire/ — Akeso Inc. (9926. HK, “Akeso”) announced today that China’s National Medical Products Administration (NMPA) has accepted its New Drug Application (NDA) for its fully human anti-PCSK9 monoclonal antibody ebronucimab (AK102) for 2 indications 1) primary hypercholesterolemia and mixed hyperlipidemia, and 2) heterozygous familial hypercholesterolemia (HeFH). Ebronucimab is jointly developed … Read more
Vincent Begaud, psychologist and EMDR therapist, has just joined the medical team of the Maison de Santé des Amandiers. EMDR is a therapy that consists of healing traumas and phobias through right-to-left eye movements and is aimed at people who are phobic or have post-traumatic disorders. Discovered by chance in 1987 by psychologist Francine Shapiro … Read more